DE69321134D1 - Plasminogen-derivate die durch thrombin aktivierbar sind - Google Patents

Plasminogen-derivate die durch thrombin aktivierbar sind

Info

Publication number
DE69321134D1
DE69321134D1 DE69321134T DE69321134T DE69321134D1 DE 69321134 D1 DE69321134 D1 DE 69321134D1 DE 69321134 T DE69321134 T DE 69321134T DE 69321134 T DE69321134 T DE 69321134T DE 69321134 D1 DE69321134 D1 DE 69321134D1
Authority
DE
Germany
Prior art keywords
thrombin
activated
amino acid
acid residue
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69321134T
Other languages
English (en)
Other versions
DE69321134T2 (de
Inventor
Richard James Gilbert
Michael George Hunter
Keith Martyn Dawson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
British Biotech Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharmaceuticals Ltd filed Critical British Biotech Pharmaceuticals Ltd
Publication of DE69321134D1 publication Critical patent/DE69321134D1/de
Application granted granted Critical
Publication of DE69321134T2 publication Critical patent/DE69321134T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6435Plasmin (3.4.21.7), i.e. fibrinolysin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21007Plasmin (3.4.21.7), i.e. fibrinolysin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
DE69321134T 1992-10-29 1993-10-28 Plasminogen-derivate die durch thrombin aktivierbar sind Expired - Lifetime DE69321134T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929222758A GB9222758D0 (en) 1992-10-29 1992-10-29 Proteins and nucleic acids
PCT/GB1993/002219 WO1994010318A1 (en) 1992-10-29 1993-10-28 Thrombin activatable plasminogen derivatives

Publications (2)

Publication Number Publication Date
DE69321134D1 true DE69321134D1 (de) 1998-10-22
DE69321134T2 DE69321134T2 (de) 1999-02-25

Family

ID=10724266

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69321134T Expired - Lifetime DE69321134T2 (de) 1992-10-29 1993-10-28 Plasminogen-derivate die durch thrombin aktivierbar sind

Country Status (15)

Country Link
EP (1) EP0666920B1 (de)
JP (1) JP3329340B2 (de)
AT (1) ATE171213T1 (de)
AU (1) AU674180B2 (de)
CA (1) CA2145749C (de)
DE (1) DE69321134T2 (de)
DK (1) DK0666920T3 (de)
ES (1) ES2123669T3 (de)
FI (1) FI114102B (de)
GB (1) GB9222758D0 (de)
HK (1) HK1008047A1 (de)
NO (1) NO317661B1 (de)
NZ (1) NZ257175A (de)
WO (1) WO1994010318A1 (de)
ZA (1) ZA938120B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412131D0 (en) * 1994-06-17 1994-08-10 British Bio Technology Thrombolytic composition
BR9711015A (pt) * 1996-08-02 1999-08-17 Boehringer Mannheim Gmbh Ativador de plasminog-nio capaz de ser ativado por trombina
AU2002218890A1 (en) 2000-12-21 2002-07-01 Thromb-X N.V. A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell
WO2003066842A2 (de) * 2002-02-06 2003-08-14 Trommsdorff Gmbh & Co. Kg Arzneimittel Verfahren zur herstellung von rekombinanten proteinen in mikroorganismen
FR2841904B1 (fr) * 2002-07-03 2004-08-20 Inst Nat Sante Rech Med Analogues de facteurs x clivables par la thrombine
PL213309B1 (pl) 2006-02-09 2013-02-28 Polska Akademia Nauk Inst Biochemii I Biofizyki Sposób hydrolizy wiazania peptydowego

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids

Also Published As

Publication number Publication date
GB9222758D0 (en) 1992-12-09
ES2123669T3 (es) 1999-01-16
NZ257175A (en) 1996-07-26
NO317661B1 (no) 2004-11-29
AU674180B2 (en) 1996-12-12
EP0666920A1 (de) 1995-08-16
DK0666920T3 (da) 1999-06-14
EP0666920B1 (de) 1998-09-16
CA2145749C (en) 2005-06-21
NO951648D0 (no) 1995-04-28
DE69321134T2 (de) 1999-02-25
FI952071A (fi) 1995-04-28
JP3329340B2 (ja) 2002-09-30
CA2145749A1 (en) 1994-05-11
JPH08504575A (ja) 1996-05-21
ZA938120B (en) 1994-08-01
FI952071A0 (fi) 1995-04-28
HK1008047A1 (en) 1999-04-30
WO1994010318A1 (en) 1994-05-11
ATE171213T1 (de) 1998-10-15
FI114102B (fi) 2004-08-13
AU5343294A (en) 1994-05-24
NO951648L (no) 1995-04-28

Similar Documents

Publication Publication Date Title
DK1288223T3 (da) Terapeutiske peptidderivater
MY119155A (en) New peptide derivatives
DE3871965D1 (de) Steroid-5-alpha-reduktase-inhibitoren.
DE3684680D1 (de) Peptidplasminogenaktivatoren.
DK0547932T3 (da) Fremgangsmåde til fremstilling af et koncentrat af aktiveret faktor VII med høj renhed
ATE172451T1 (de) Vitamin d analoge
ATE189390T1 (de) Antiproliferative substituierte 5-thiapyrimidinon-und 5-selenopyrimidinonverbindungen
ES2088860T3 (es) Activador plasminogenico de tipo tisular humano modificado y su preparacion.
DE69321134D1 (de) Plasminogen-derivate die durch thrombin aktivierbar sind
FI962480A0 (fi) Bisnoralkoholin muuntaminen bisnoraldehydiksi
UA27132C2 (uk) Двофуhкціоhальhі варіаhти урокіhази зі зміцнеhою фібриhолітичhою властивістю і тромбіh-іhгібуючою дією
EP0351246A3 (de) Gewebeplasminogenaktivator-Analog
ATE60788T1 (de) Derivat von p-aminophenol mit mucrosekretolytischer fluessiger und antipyretischer wirksamkeit, dessen verfahren zur herstellung und dessen pharmazeutische zusammensetzungen.
GB2286190A (en) Thrombin activatable plasminogen derivatives
AU3332389A (en) Monoclonal antibodies to tissue plasminogen activator (t-pa) which prolong its functional half-life
DK0589741T3 (da) Anvendelse af en direkte thrombininhibitor til fremstilling af et lægemiddel med thrombolytisk aktivitet
ATE103178T1 (de) T-pa pro stabilisierung.
ID22910A (id) Metode untuk memproduksi fibrinogen
MASON Mercurial activation of human cathepsin L

Legal Events

Date Code Title Description
8364 No opposition during term of opposition